Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist (Q43177434)
Jump to navigation
Jump to search
scientific article published on 2 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist |
scientific article published on 2 February 2010 |
Statements
1 reference
Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist (English)
1 reference
Brendan M Johnson
1 reference
Laurel M Adams
1 reference
Ke Zhang
1 reference
Shelby D Gainer
1 reference
Lyndon C Kirby
1 reference
Robert A Blum
1 reference
Glen Apseloff
1 reference
Royce A Morrison
1 reference
Ralph A Schutz
1 reference
Peter F Lebowitz
1 reference
2 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference